Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of Ambroxol as Therapy for Gaucher Disease
Xia Zhan, Huiwen Zhang, Gustavo Maegawa, et al.
JAMA Network Open (2023) Vol. 6, Iss. 6, pp. e2319364-e2319364
Open Access | Times Cited: 12

Showing 12 citing articles:

Exploring the efficacy and safety of Ambroxol in Gaucher disease: an overview of clinical studies
Feda E. Mohamed, Fatma Al‐Jasmi
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
The use of Ambroxol for the treatment of Gaucher disease: A systematic review
Diego Agustín Abelleyra Lastoria, S. Grewal, Derralynn Hughes
eJHaem (2024) Vol. 5, Iss. 1, pp. 206-221
Open Access | Times Cited: 6
GBA1-Associated Parkinson’s Disease Is a Distinct Entity
Aliaksandr Skrahin, Mia Horowitz, Majdolen Istaiti, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7102-7102
Open Access | Times Cited: 4
Beyond the lungs: Exploring diverse applications of bromhexine and ambroxol
Elham Ahmadi, Arya Afrooghe, Zahra Soltani, et al.
Life Sciences (2024) Vol. 353, pp. 122909-122909
Closed Access | Times Cited: 3
Ambroxol as Therapy for Gaucher Disease—Ambitious but Ambivalent
Neal J. Weinreb, Özlem Göker-Alpan
JAMA Network Open (2023) Vol. 6, Iss. 6, pp. e2319336-e2319336
Open Access | Times Cited: 5
Functional Analysis of Human GBA1 Missense Mutations in Drosophila: Insights into Gaucher Disease Pathogenesis and Phenotypic Consequences
Aparna Kuppuramalingam, Or Cabasso, Mia Horowitz
Cells (2024) Vol. 13, Iss. 19, pp. 1619-1619
Open Access | Times Cited: 1
Cost-effectiveness of ambroxol in the treatment of Gaucher disease type 2
Miloš Milosavljević, Medo Gutić, Vladimir Janjić, et al.
Open Medicine (2024) Vol. 19, Iss. 1
Open Access
Ambroxol

Reactions Weekly (2024) Vol. 2014, Iss. 1, pp. 37-37
Closed Access
Electroencephalogram and phenotype patterns in neuronopathic Gaucher disease patients – ten years of experience in a single center
Xiying Yang, Yan Meng, Jian Chen, et al.
Acta Epileptologica (2024) Vol. 6, Iss. 1
Open Access
Finding Second-Generation Pharmacochaperones: Getting Help From Computational Methods
Anna Verdino, Bernardina Scafuri, Damiano Parrone, et al.
Elsevier eBooks (2024)
Closed Access
Recent Therapeutic Advancements for Gaucher Disease
Lipi Pradhan, Sumit Manna, Pragya Pragya, et al.
Advanced Therapeutics (2024) Vol. 8, Iss. 1
Open Access
Unveiling the antibacterial action of ambroxol against Staphylococcus aureus bacteria: in vitro, in vivo, and in silico investigation
Ahmed Abdelaziz, Amal M. Abo-Kamar, Alaa E. Ashour, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access
Page 1

Scroll to top